Jacobs Receives Pharmaceuticals Pilot Plant Contract from Novo Nordisk
September 30 2014 - 7:45AM
Business Wire
Leveraging Technical and Global Reach for
Innovative Capacity Expansion
Jacobs Engineering Group Inc. (NYSE:JEC) announced today that it
has been awarded a contract from Novo Nordisk for a research and
development facility in Bagsværd, Denmark.
Officials did not disclose the contract value.
Under the terms of the contract, Jacobs is providing
engineering, procurement and construction management services for a
new purification pilot plant project, which initially involves one
purification line.
The project is expected to expand Novo Nordisk’s capacity to
produce active pharmaceutical ingredients for a growing number of
diabetes drugs in development. The pilot plant is expected to be
fully operational by late 2016. The facility has the potential to
be expanded twofold in the future to provide further production
capacity.
In making the announcement, Jacobs Group Vice President Conor
Doyle stated, “As the largest provider of professional technical
services to the biopharmaceutical industry, we look forward to
contributing our wide industry knowledge and global perspective on
the design of Good Manufacturing Practices facilities to help Novo
Nordisk meet their project goals.”
“We expect the new purification pilot plant to significantly
increase our capacity for early-phase diabetes projects,” said
Jesper Bᴓving, Senior Vice President, CMC Supply, part of Novo
Nordisk R&D.
Headquartered in Denmark, Novo Nordisk is a global healthcare
company with 90 years of innovation and leadership in areas such as
diabetes care. Novo Nordisk employs approximately 40,000 employees
in 75 countries and markets its products in more than 180
countries.
Jacobs is one of the world's largest and most diverse providers
of technical professional and construction services.
Statements made in this release that are not based on historical
fact are forward-looking statements. We base these forward-looking
statements on management’s current estimates and expectations as
well as currently available competitive, financial and economic
data. Forward-looking statements, however, are inherently
uncertain. There are a variety of factors that could cause business
results to differ materially from our forward-looking
statements. For a description of some of the factors which may
occur that could cause actual results to differ from our
forward-looking statements please refer to our 2013 Form 10-K, and
in particular the discussions contained under Items 1 - Business,
1A - Risk Factors, 3 - Legal Proceedings, and 7 - Management's
Discussion and Analysis of Financial Condition and Results of
Operations. We do not undertake to update any forward-looking
statements made herein.
Jacobs Engineering Group Inc.Michelle Jones, 626-578-6968
Jacobs Engineering (NYSE:JEC)
Historical Stock Chart
From Aug 2024 to Sep 2024
Jacobs Engineering (NYSE:JEC)
Historical Stock Chart
From Sep 2023 to Sep 2024